Abstract | BACKGROUND AND AIM: METHODS: This was a multicenter, retrospective study of consecutive patients with BE who received LNC following endoscopic mucosal resection (EMR) of IMCA. The outcomes evaluated were complete eradication of dysplasia and intestinal metaplasia and development of invasive cancer during follow up. The follow-up period was at least 1 year from initial LNC. RESULTS: Twenty-seven patients were identified. The median Prague score was C3M5 (range C0M1-C14M14). After EMR+LNC, the median Prague score was C0M1 (range C0M0-C9M10); 22/27 patients (82%) achieved complete eradication of dysplasia after cryotherapy, and 19/27 patients (70%) achieved complete eradication of intestinal metaplasia. One out of 27 patients (4%) developed invasive cancer (disease beyond IMCA) over the study period. CONCLUSION:
Cryotherapy is an effective endoscopic tool for eradication of BE dysplasia after EMR for IMCA. Development of invasive cancer is low for this high-risk group.
|
Authors | Arvind J Trindade, Douglas K Pleskow, Neil Sengupta, Shivangi Kothari, Sumant Inamdar, Joshua Berkowitz, Vivek Kaul |
Journal | Journal of gastroenterology and hepatology
(J Gastroenterol Hepatol)
Vol. 33
Issue 2
Pg. 461-465
(Feb 2018)
ISSN: 1440-1746 [Electronic] Australia |
PMID | 28770555
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | © 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. |
Chemical References |
|
Topics |
- Adenocarcinoma
(complications, surgery)
- Aged
- Aged, 80 and over
- Barrett Esophagus
(etiology, therapy)
- Cryotherapy
(methods)
- Disease Progression
- Esophageal Neoplasms
(complications, surgery)
- Esophagoscopy
- Female
- Humans
- Male
- Middle Aged
- Nitrogen
(therapeutic use)
- Retrospective Studies
- Risk
|